Sierra World Equity Review has initiated coverage of MER Telemanagement Solutions (MTSL)
Known for her accurate forecasts and predictions Sierra World Equity Review will be featuring several articles about MER Telemanagement Solutions over the course of the next week.
Sierra World Equity Review is very accurate and independent, look for breaking new articles and frequent updates as Sierra focuses intense coverage on this stock. Sierra has an extensive network of very reliable and accurate sources, recently Sierra was the only Stock Review who called correctly TWO different FDA recent bio-tech drug decisions, in fact we called them unequivocally and days in advance...here's the proof: Sierra called it correctly days in advance for two obesity drugs under consideration by the FDA, the FDA had not given it's approval for over 12 years to any obesity drugs yet Sierra World Equity Review bucked the consensus and was CORRECT when when Belviq from Arena Pharmaceuticals was approved by the FDA and also CORRECTLY that Qnexa (Qsymia) from Vivus would be approved by the FDA (just look at the links below for proof!!). Repeating, we are VERY ACCURATE in our predictions and targets.
links to FDA predictions:
published June 26 2012 - Arena and Lorcaserin
Sierra World Equity Review hopes you will enjoy our articles about MER Telemanagement Solutions, prosper and even join Sierra at one of her stock parties...Sierra will tell you when and where......Sierra World Equity Review currently hold no positions in MER Telemanagement Solutions.....be the first to read our new posts follow us on Twitter at https://twitter.com/#!/SierraEquity
